BPH Global Ltd Stock

Equities

BP8

AU0000284366

Biotechnology & Medical Research

Delayed Australian S.E. 07:59:59 2024-05-22 pm EDT 5-day change 1st Jan Change
0.001 AUD 0.00% Intraday chart for BPH Global Ltd 0.00% -33.33%
Sales 2022 14.35M 9.5M Sales 2023 339 224.4 Capitalization 3.85M 2.55M
Net income 2022 -3M -1.99M Net income 2023 -4M -2.65M EV / Sales 2022 1.07 x
Net Debt 2022 627K 415K Net cash position 2023 511K 338K EV / Sales 2023 9,862 x
P/E ratio 2022
-3.98 x
P/E ratio 2023
-0.72 x
Employees 31
Yield 2022 *
-
Yield 2023
-
Free-Float 35.24%
More Fundamentals * Assessed data
Dynamic Chart
3 months-50.00%
Current year-33.33%
More quotes
1 week
0.00
Extreme 0.001
0.00
1 month
0.00
Extreme 0.001
0.00
Current year
0.00
Extreme 0.001
0.00
1 year
0.00
Extreme 0.001
0.00
3 years
0.00
Extreme 0.001
0.02
5 years
0.00
Extreme 0.001
0.05
10 years
0.00
Extreme 0.001
1.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 23-03-29
Corporate Secretary - Apr. 10
Members of the board TitleAgeSince
Director/Board Member - 21-07-20
Chairman 63 20-03-30
Director/Board Member - 19-05-26
More insiders
Date Price Change Volume
24-05-22 0.001 0.00% 200 000
24-05-20 0.001 0.00% 1,500
24-05-16 0.001 0.00% 19,628

Delayed Quote Australian S.E., May 22, 2024 at 07:59 pm EDT

More quotes
BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. The Company produces its products through various plants, which include Caulerpa lentillifera, Dendrobium officinale, Resina and Cannabis sativa. It is also into the sales and distribution of bird's nest products in China. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, and SCU Southeast Asia Sdn Bhd, SCU (HK) Ltd.
More about the company